Molecular Diagnostics
Personalized Tumor-Informed Assay Helps Patients Get Ahead of Cancer
Over the past several years, research has shown that minimal or molecular residual disease (MRD) monitoring can reliably identify lung cancer patients at high risk of relapse, detect post-surgical recurrence often earlier than standard imaging, assess therapy response, and potentially act as a surrogate for clinical trial endpoints. Now, a newly-available platform can help detect MRD in patients with solid tumors. More...22 Mar 2022
Worm-on-a-Chip Device Could Noninvasively Diagnose Early-Stage Cancer
Dogs can use their incredible sense of smell to sniff out various forms of cancer in human breath, blood and urine samples. Similarly, in the lab a much simpler organism, the roundworm C. elegans, wriggles its way toward cancer cells by following an odor trail. Scientists have now reported a device that uses the tiny worms to detect lung cancer cells. More...22 Mar 2022
Pediatric Cancer Sequencing Expands Relapse Treatment Options
New data has demonstrated that sequencing the tumors of relapsing pediatric cancer patients can uncover alterations linked to existing and emerging targeted therapies, potentially offering improved outcomes over standard chemotherapy. More...21 Mar 2022
Blood Plasma Biomarkers Could Improve Diagnostic Tests for Alzheimer's Disease
Alzheimer's disease is the most common form of dementia, with the African American population at the greatest risk for developing the disease. The findings of the first study to focus on RNA molecules in plasma as biomarkers for Alzheimer's disease in African Americans could lead to the development of improved diagnostic tests for the disease. More...18 Mar 2022
Groundbreaking DNA Test Evaluates Biomarkers in 517 Cancer-Relevant Genes across 30 Types of Solid Tumors
Illumina Inc. (San Diego, CA, USA) has launched TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer. More...17 Mar 2022
Single Cell Characterization Acral Melanoma Identifies Novel Targets for Immunotherapy
Acral melanoma is a rare subtype that represents roughly 3% of all melanoma cases. Unlike typical melanoma that occurs on sun-exposed skin, acral melanoma develops on the nonhair bearing skin of the soles, palm and nail beds. There is very little information known about the development of acral melanoma. More...16 Mar 2022
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Capillary Blood Collection Tube
IMPROMINI M3
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
In Other News
New Test Could Help Diagnose Lyme Disease Sooner and Determine Treatment Efficacy
Expression, Microbiome Features Provide Pre-Treatment Lung Function Clues for Pediatric Patients
Next-Gen Graphene Biosensor Technology Enables Lab Quality Diagnostics of Infectious Diseases, Anytime, Anywhere
Two Circulating Biomarkers Predict Cardiovascular Disease Risk in Psoriasis Patients
Fecal Microbiome Signature Predicts Pancreatic Cancer Risk
Stem Cell Architecture Drives Myelodysplastic Syndrome Progression
Single Test for Over 50 Genetic Diseases Cuts Diagnosis from Decades to Days
Paper-Based Portable Diagnostic Platform Accurately Detects Mosquito-Borne Diseases Under Field Conditions
Low-Cost Multiplexed Electrochemical Biomarker Detection Platform to Be Commercialized in POC Diagnostics
Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases
'Fingerprint' Machine Learning Technique Identifies Different Bacteria in Seconds
Liquid Biopsy of Cerebrospinal Fluid for Diagnosis of Medulloblastoma
Single-Antigen Assays Increase Clinical Laboratory's Ability to Identify Acceptable Donors for Transplants
Prognostic Test Identifies High Risk and Low Risk Smoldering Multiple Myeloma Patients
Epigenetic Biomarker Signature Predicts the Likelihood of Premature Birth
Semiconductor Microchip Detects Prostate Cancer Markers With Ultra-High Sensitivity
Biomérieux Launches Free Mobile App to Aid Clinicians in Emergency and Critical Care Diagnostics
Mitochondrial Damage May Explain the Increased Incidence of Hypertension in Black Adults
TTMV-HPV DNA Biomarker Predicts Recurrence of Oropharynx Cancer
Two Important Cardiovascular Disease Risk Factors Operate Independently
Sensitive Diagnostic Test for Alzheimer’s Disease Demonstrates Accuracy Over Multiple Laboratories and Protocols
Novel Biomarkers Predict Response of Melanoma Patients to Immunotherapy
Whole-Genome Sequencing Diagnoses Neurological Repeat Expansion Disorders
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
